通过远程多参数监测指导的心力衰竭管理:元分析
Andrea Zito1, Attilio Restivo1, Giuseppe Ciliberti1
1Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy.
International journal of cardiology
|July 10, 2023
概括
基于植入物的远程监测通过减少住院和全因死亡,显著改善了心力衰竭 (HF) 管理. 与HF患者的标准护理相比,这种策略提供了更好的临床结果.
科学领域:
- 心脏病学 心脏病学
- 医疗技术 医疗技术 医学技术
- 医疗信息学 医疗信息学
背景情况:
- 植入式设备为心力衰竭 (HF) 管理提供远程监控.
- 这些设备跟踪临床前标记物,以预测脱补偿和预防住院治疗.
- 关键的监测因素包括自主适应,患者活动和胸内阻抗.
研究的目的:
- 评估基于植入物的多参数远程监测是否能改善高频管理中的临床结果.
- 将这种先进的策略与标准的临床护理进行比较.
主要方法:
- 来自PubMed,Embase和CENTRAL的随机对照试验 (RCT) 的系统文献研究.
- 使用Poisson回归与随机研究效应来计算发病率比率 (IRR) 和95%置信区间 (CI) 的元分析.
- 主要结局:所有死因和HF住院的综合结局;次要结局:个别组件.
主要成果:
- 包括6个RCT,4869名患者和18个月的平均随访时间.
- 多个参数引导的HF管理降低了复合结果风险 (IRR 0.83,95%CI 0.71-0.99).
- 在HF住院 (IRR 0.75,95%CI 0.61-0.93) 和因任何原因死亡 (IRR 0.80,95%CI 0.66-0.96) 均观察到显著减少.
结论:
- 基于植入物的多参数远程监测为高频管理提供了显著的临床益处.
- 这一策略有效地减少了HF住院事件和全因死亡率.
- 这些发现支持其在标准临床护理中的使用,以改善患者的治疗结果.
相关概念视频
01:30Heart Failure V: Medical Management
14
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14
01:30Heart Failure VII: Nursing Interventions
99
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
99
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:28Mitral Regurgitation IV: Nursing Management
50
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
50
01:30Heart Failure IV: Classification and Diagnostic Evaluation
20
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465